Advanced Search

CN 34-1304/RISSN 1674-3679

Volume 20 Issue 10
Oct.  2016
Turn off MathJax
Article Contents
KUANG Man-hua, XIONG Wen-jing, XIE Xin-xin, LIU Ye, LIU Yang, RANG Wei-qing. Safety of oral iron supplements for iron deficiency anemia in children: a network meta-analysis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2016, 20(10): 1047-1052. doi: 10.16462/j.cnki.zhjbkz.2016.10.021
Citation: KUANG Man-hua, XIONG Wen-jing, XIE Xin-xin, LIU Ye, LIU Yang, RANG Wei-qing. Safety of oral iron supplements for iron deficiency anemia in children: a network meta-analysis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2016, 20(10): 1047-1052. doi: 10.16462/j.cnki.zhjbkz.2016.10.021

Safety of oral iron supplements for iron deficiency anemia in children: a network meta-analysis

doi: 10.16462/j.cnki.zhjbkz.2016.10.021
  • Received Date: 2016-04-21
  • Rev Recd Date: 2016-07-18
  • Objective To compare and evaluate the safety of eight kinds of oral iron supplements that treat children with iron deficiency anemia(IDA) by using Network Meta-analysis. Methods We searched and collected domestic and foreign literatures on oral iron supplement for iron deficiency anemia children in CNKI, PubMed, Cochrane Library and Science Direct Database from the inception to July 2015. Statistical analysis was performed by Microsoft Excel 2013 software, we used the NetMetaXL macros in it to load the WinBUGS 1.4.3 software to conduct the calculate by random effects Bayesian models. The odds ratios (ORs) and mean ranking and the probability among eight kinds of oral irons were estimated. Results We identified 31 eligible studies which involved 3 417 children with IDA. In network analyses, there was higher risk that ferrous sulfate(OR=0.00, 95% CI:0.00-0.03), sodium iron chlorophyll (OR=0.03, 95% CI:0.00-0.39), ferrous succinate (OR=0.02, 95% CI:0.00-0.23), ferrous gluconate(OR=0.01, 95% CI: 0.00-0.07), multidimensional iron compounds(OR=0.01 95% CI:0.00-0.11), iron polymaltose complex(OR=0.02, 95% CI:0.00-0.19) and ferrous fumarate (OR=0.01, 95% CI:0.00-0.12) prevented side-effects when compared to iron dextran. Although iron dextran was ranked the regiment with the least favorable adverse event profile among eight kinds of oral irons (SUCRA=0.999 4), ferrous sulfate was the highest risk (SUCRA=0.034 1). Conclusions Our results suggest that consumers and clinicians might be more cautious when using ferrous sulfate to treat children with IDA, because of its highest risk among other oral iron supplements.
  • loading
  • Lukowski AF, Koss M, Burden MJ, et al. Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory[J]. Nutr Neurosci, 2010,13(2): 54-70.
    安森亮. 琥珀酸亚铁和硫酸亚铁治疗小儿缺铁性贫血的疗效比较[J]. 医学综述, 2015,21(3): 550-552.
    翁文娃, 李燕玲. 多维铁治疗婴幼儿缺铁性贫血的临床观察[J]. 海南医学, 2012, 23(14): 53-54.
    汪萌, 叶袆. 多糖铁复合物治疗青少年缺铁性贫血效果观察[J]. 中国乡村医药, 2011, 18(9): 23-24.
    唐利民, 邓孝智. 生血宁治疗儿童缺铁性贫血临床疗效观察[J]. 四川医学, 2011, 32(5): 745-746.
    全玉红, 白英丽. 力蜚能治疗小儿营养性缺铁性贫血36例疗效观察[J]. 中国医学创新, 2012, 9(31): 102-103.
    刘燕. 右旋糖酐铁口服液治疗小儿营养性缺铁性贫血的疗效观察[J]. 临床合理用药杂志, 2012, 5(9): 53.
    刘茂兰. 多维铁口服液治疗儿童缺铁性贫血的疗效观察[J]. 中国中医药咨讯, 2011,3(6): 154.
    王艳, 王培红, 李媛媛. 右旋糖酐铁口服液治疗婴儿缺铁性贫血疗效观察[J]. 山东医药, 2010, 50(21): 92.
    卿蕊. 多糖铁复合物治疗76例儿童缺铁性贫血疗效分析[J]. 中国现代药物应用, 2010, 4(3): 111-112.
    王爱文, 柯友辉, 陈浩波,等. 每周服用多维铁治疗学龄前儿童缺铁性贫血的疗效观察[J]. 海峡药学, 2009, 21(4): 139-140.
    王莲芳. 生血宁片治疗儿童缺铁性贫血106例[J]. 哈尔滨医药, 2004, 24(5): 30-31.
    史晓霞, 魏克民. 生血宁片治疗儿童缺铁性贫血60例[J]. 医学研究通讯, 2004, 33(7): 50-51.
    廖华, 张寿斌. 速力菲治疗小儿缺铁性贫血74例疗效观察[J]. 邯郸医学高等专科学校学报, 2002,15(5): 486.
    董守梅, 李建华, 高树英. 右旋糖酐铁片剂治疗小儿缺铁性贫血疗效观察[J]. 华夏医学, 2002,15(2):179-180.
    郑丽. 多维铁口服溶液治疗小儿缺铁性贫血疗效探讨[J]. 中外医疗, 2015, 34(6): 100-101.
    吴慧莉. 琥珀酸亚铁治疗0~3岁儿童缺铁性贫血疗效观察[J]. 医学信息, 2014, 27(32): 295.
    秦瑞娟, 卞庆素, 李海莹. 琥珀酸亚铁片治疗小儿缺铁性贫血60例临床观察[J]. 实用中西医结合临床, 2014, 14(2): 30-31.
    初灵芝, 于永锋, 张田. 富马酸亚铁治疗小儿缺铁性贫血的疗效分析[J]. 中国卫生产业, 2013, 10(15): 86-87.
    刘淑华. 多维铁口服溶液治疗小儿缺铁性贫血疗效观察[J]. 医学理论与实践, 2011, 24(11): 1304-1305.
    王彩霞, 王缨. 富马酸亚铁混悬液治疗小儿缺铁性贫血的临床观察[J]. 中国现代医生, 2009, 47(13): 149-152.
    梁荣伟. 力蜚能治疗小儿缺铁性贫血的疗效观察[J]. 医学信息(西安), 2007, 20(10): 1810-1812.
    竺晓虹, 陶立新. 琥珀酸亚铁与硫酸亚铁治疗小儿缺铁性贫血效果比较[J]. 中国乡村医药, 2014, 21(17): 14.
    Aycicek A, Koc A, Oymak Y, et al. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia[J]. J Pediatr Hematol Oncol, 2014, 36(1): 57-61.
    田发书. 琥珀酸亚铁治疗小儿缺铁性贫血临床研究[J]. 医学信息, 2013, 26(6): 197-198.
    谭咏, 王玉洁, 戴晓阳. 富马酸亚铁悬混液对缺铁性贫血患儿CHr的影响及其疗效分析[J]. 海南医学院学报, 2013, 19(11): 1582-1584.
    王智勇. 不同补铁方式治疗小儿缺铁性贫血160例疗效观察[J]. 按摩与康复医学, 2012, 3(36): 123-124.
    代兵. 琥珀酸亚铁治疗小儿缺铁性贫血临床研究[J]. 中外医疗, 2011,30(14): 56.
    Yasa B, Agaoglu L, Unuvar E. Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia[J]. Int J Pediatr, 2011, 2011:524520.
    Bopche AV, Dwivedi R, Mishra R, et al. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children[J]. Indian Pediatr, 2009, 46(10): 883-885.
    熊英, 邹典定, 宋桂英. 琥珀酸亚铁治疗小儿缺铁性贫血疗效观察[J]. 重庆医学, 2004, 33(6): 913-914.
    Kavakli K, Yilmaz D, Cetinkaya B, et al. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children[J]. Pediatr Hematol Oncol, 2004, 21(5): 403-410.
    WHO. The global burden of disease: 2004 update[M]. Geneva: WHO, 2008.
    Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, et al. Tolerability of different oral iron supplements: a systematic review[J]. Curr Med Res Opin, 2013, 29(4): 291-303.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (605) PDF downloads(18) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return